Filter
691
Filtered Results: 691
Text search:
smear
preparation
Featured
Recommendations
98
New Publications
212
Language
Document type
No document type
467
Guidelines
81
Studies & Reports
68
Manuals
41
Strategic & Response Plan
11
Training Material
10
Fact sheets
7
Brochures
3
Infographics
3
Countries / Regions
India
82
Rwanda
20
Tanzania
17
South Africa
17
Kenya
16
Western and Central Europe
16
Uganda
15
Ethiopia
15
Nepal
14
Global
13
Ghana
12
Malawi
12
Bangladesh
12
Liberia
12
Philippines
11
Eastern Europe
11
Nigeria
10
Sierra Leone
9
Zambia
9
South–East Asia Region
8
Latin America and the Carribbean
6
Namibia
6
Lesotho
5
Cambodia
4
Myanmar / Burma
4
Zimbabwe
3
Asia
3
Argentina
3
Tajikistan
2
Timor Leste/ East Timor
2
Ukraine
2
Senegal
2
Africa
2
Venezuela
2
Eastern Europe and Central Asia
2
Paraguay
2
Lebanon
2
Sri Lanka
2
Bhutan
2
Botswana
2
South Sudan
2
Indonesia
2
El Salvador
1
Benin
1
Cameroon
1
Syria
1
Burkina Faso
1
Afghanistan
1
Peru
1
Mozambique
1
Haiti
1
Jordan
1
Germany
1
Congo, Democratic Republic of
1
North America
1
Vietnam
1
Moldova
1
Mali
1
Angola
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
301
Clinical Guidelines
94
Pharmacy & Technologies
29
Public Health
26
Women & Child Health
25
Key Resources
21
Capacity Building
13
Toolboxes
TB
157
NTDs
47
HIV
33
Malaria
24
Rapid Response
19
Mental Health
18
Refugee
14
Caregiver
14
Ebola & Marburg
13
AMR
11
COVID-19
10
Pharmacy
10
Natural Hazards
8
Polio
7
Specific Hazards
6
Disability
5
Conflict
5
Planetary Health
4
Global Health Education
3
Cholera
2
NCDs
2
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where the world wants to be in terms of NCD prevention a...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Developmental disorders
Chapter C.4
With this study, we estimated the burden of serious fungal infections for the general healthy population and for those at risk, including those infected with HIV, patients with asthma, as well as those under intensive care. We also highlight from studies in progress of high incidences of histoplasm...
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p...
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...
• diagnosis of HIV
• update on the initiation of ART<...
Integrated Management of pregnancy and childbirth
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
recommended
2nd edition, July 2021. This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendati...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
